Development of a Full-Thickness Human Skin Equivalent in Vitro Model Derived from TERT-Immortalized Keratinocytes and Fibroblasts

Tissue Engineering - Part A

Volumn 21, Issue 17-18, 2015, Pages 2448-2459

  Reijnders, Christianne M A ^a   Van Lier, Amanda ^a   Roffel, Sanne ^a   Kramer, Duco ^b   Scheper, Rik J ^a   Gibbs, Susan ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLASTS; MICROSTRUCTURE; TISSUE;

BASEMENT MEMBRANE; EXTRACELLULAR MATRICES; HEMATOXYLIN EOSIN; HUMAN CELL LINES; HUMAN SKIN CELLS; RE-EPITHELIALIZATION; SKIN EQUIVALENTS; WOUND HEALING ASSAYS;

CELL CULTURE;

COLLAGEN TYPE 3; HEMATOXYLIN; CHEMOKINE; TELOMERASE;

ARTICLE; BASEMENT MEMBRANE; BURN; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL PROLIFERATION; COLD INJURY; CONTROLLED STUDY; DESMOSOME; ELECTRON MICROSCOPY; EPITHELIZATION; EXTRACELLULAR MATRIX; FIBROBLAST; HEMIDESMOSOME; HUMAN; HUMAN CELL; HUMAN SKIN EQUIVALENT; IMMORTALIZED CELL LINE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KERATINOCYTE; PHYSICAL ACTIVITY, CAPACITY AND PERFORMANCE; PRIORITY JOURNAL; SKINFOLD THICKNESS; ULTRASTRUCTURE; WOUND HEALING; ARTIFICIAL SKIN; BIOLOGICAL MODEL; CYTOLOGY; DERMIS; EPIDERMIS; MALE; METABOLISM; SECRETION (PROCESS); TRANSFORMED CELL LINE;

CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CHEMOKINES; DERMIS; EPIDERMIS; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MALE; MODELS, BIOLOGICAL; SKIN, ARTIFICIAL; TELOMERASE; WOUND HEALING;

EID: 84940706684     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2015.0139     Document Type: Article

References (68)

1. Pappinen, S., Pryazhnikov, E., Khiroug, L., Ericson, M.B., Yliperttula, M., and Urtti, A. Organotypic cell cultures and two-photon imaging: tools for in vitro and in vivo assessment of percutaneous drug delivery and skin toxicity. J Control Release 161, 656, 2012.
2. Groeber, F., Holeiter, M., Hampel, M., Hinderer, S., and Schenke-Layland, K. Skin tissue engineering-in vivo and in vitro applications. Adv Drug Deliv Rev 63, 352, 2011.
3. Mathes, S.H., Ruffner, H., and Graf-Hausner, U. The use of skin models in drug development. Adv Drug Deliv Rev 69, 81, 2014.
4. Gibbs, S. In vitro irritation models and immune reactions. Skin Pharmacol Physiol 22, 103, 2009.
5. Gibbs, S., Corsini, E., Spiekstra, S.W., Galbiati, V., Fuchs, H.W., Degeorge, G., et al. An epidermal equivalent assay for identification and ranking potency of contact sensitizers. Toxicol Appl Pharmacol 15, 529, 2013.
6. Xie, Y., Rizzi, S.C., Dawson, R., Lynam, E., Richards, S., Leavesley, D.I., et al. Development of a three-dimensional human skin equivalent wound model for investigating novel wound healing therapies. Tissue Eng Part C Methods 16, 1111, 2010.
7. Coolen, N.A., Schouten, K.C., Boekema, B.K., Middelkoop, E., and Ulrich, M.M. Wound healing in a fetal, adult, and scar tissue model: a comparative study. Wound Repair Regen 18, 291, 2010.
8. MacNeil, S. Progress and opportunities for tissue-engineered skin. Nature 445, 874, 2007.
9. Breetveld, M., Richters, C.D., Rustemeyer, T., Scheper, R.J., and Gibbs, S. Comparison of wound closure after burn and cold injury in human skin equivalents. J Invest Dermatol 126, 1918, 2006.
10. van den Broek, L.J., Niessen, F.B., Scheper, R.J., and Gibbs, S. Development, validation and testing of a human tissue engineered hypertrophic scar model. ALTEX 29, 389, 2012.
11. Coolen, N.A., Vlig, M., van den Bogaerdt, A.J., Middelkoop, E., and Ulrich, M.M. Development of an in vitro burn wound model. Wound Repair Regen 16, 559, 2008.
12. Haisma, E.M., de, B.A., Chan, H., van Dissel, J.T., Drijfhout, J.W., Hiemstra, P.S., et al. LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalents. Antimicrob Agents Chemother 58, 4411, 2014.
13. van den Broek, L.J., Limandjaja, G.C., Niessen, F.B., and Gibbs, S. Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective. Exp Dermatol 23, 382, 2014.
14. Shepherd, J., Douglas, I., Rimmer, S., Swanson, L., and MacNeil, S. Development of three-dimensional tissue-engineered models of bacterial infected human skin wounds. Tissue Eng Part C Methods 15, 475, 2009.
15. Popov, L., Kovalski, J., Grandi, G., Bagnoli, F., and Amieva, M.R. Three-dimensional human skin models to understand Staphylococcus aureus skin colonization and infection. Front Immunol 5, 41, 2014.
16. Gibbs, S., van de Sandt, J.J., Merk, H.F., Lockley, D.J., Pendlington, R.U., and Pease, C.K. Xenobiotic metabolism in human skin and 3D human skin reconstructs: a review. Curr Drug Metab 8, 758, 2007.
17. Gotz, C., Pfeiffer, R., Tigges, J., Blatz, V., Jackh, C., Freytag, E.M., et al. Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I). Exp Dermatol 21, 358, 2012.
18. Hewitt, N.J., Edwards, R.J., Fritsche, E., Goebel, C., Aeby, P., Scheel, J., et al. Use of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations. Toxicol Sci 133, 209, 2013.
19. Lemper, M., Snykers, S., Vanhaecke, T., De, P.K., and Rogiers, V. Current status of healthy human skin models: can histone deacetylase inhibitors potentially improve the present replacement models? Skin Pharmacol Physiol 27, 36, 2014.
20. Cohen, C., Dossou, K.G., Rougier, A., and Roguet, R. Episkin: an in vitro model for the evaluation of phototoxicity and sunscreen photoprotective properties. Toxicol In Vitro 8, 669, 1994.
21. Lelievre, D., Justine, P., Christiaens, F., Bonaventure, N., Coutet, J., Marrot, L., et al. The EpiSkin phototoxicity assay (EPA): development of an in vitro tiered strategy using 17 reference chemicals to predict phototoxic potency. Toxicol In Vitro 21, 977, 2007.
22. Gibbons, M.C., Foley, M.A., and Cardinal, K.O. Thinking inside the box: keeping tissue-engineered constructs in vitro for use as preclinical models. Tissue Eng Part B Rev 19, 14, 2013.
23. Gibbs, S., Silva Pinto, A.N., Murli, S., Huber, M., Hohl, D., and Ponec, M. Epidermal growth factor and keratinocyte growth factor differentially regulate epidermal migration, growth, and differentiation. Wound Repair Regen 8, 192, 2000.
24. Ponec, M. Reconstruction of human epidermis on de-epidermized dermis: expression of differentiation-specific protein markers and lipid composition. Toxicol In Vitro 5, 597, 1991.
25. Regnier, M., Prunieras, M., and Woodley, D. Growth and differentiation of adult human epidermal cells on dermal substrates. Front Matrix Biol 9, 4, 1981.
26. Bell, E., Paul Ehrlich, H., Buttle, D., and Nakatsuij, T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 211, 1052, 1981.
27. Navarro, J.M., Casatorres, J., and Jorcano, J.L. Elements controlling the expression and induction of the skin hyperproliferation-associated keratin K6. J Biol Chem 270, 21362, 1995.
28. Korver, J.E., van Duijnhoven, M.W., Pasch, M.C., van Erp, P.E., and van de Kerkhof, P.C. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis. Br J Dermatol 155, 688, 2006.
29. Fuchs, E. Epidermal differentiation: the bare essentials. J Cell Biol 111, 2807, 1990.
30. Corcuff, P., Fiat, F., and Minondo, A.M. Ultrastructure of the human stratum corneum. Skin Pharmacol Appl Skin Physiol 14 (Suppl 1), 4, 2001.
31. van der Wier, G., Jonkman, M.F., Pas, H.H., and Diercks, G.F. Ultrastructure of acantholysis in pemphigus foliaceus re-examined from the current perspective. Br J Dermatol 167, 1265, 2012.
32. Kitajima, Y. New insights into desmosome regulation and pemphigus blistering as a desmosome-remodeling disease. Kaohsiung J Med Sci 29, 1, 2013.
33. van der Wier, G., Pas, H.H., Kramer, D., Diercks, G.F., and Jonkman, M.F. Smaller desmosomes are seen in the skin of pemphigus patients with anti-desmoglein 1 antibodies but not in patients with anti-desmoglein 3 antibodies. J Invest Dermatol 134, 2287, 2014.
34. Breitkreutz, D., Koxholt, I., Thiemann, K., and Nischt, R. Skin basement membrane: the foundation of epidermal integrity-BM functions and diverse roles of bridging molecules nidogen and perlecan. Biomed Res Int 2013, 179784, 2013.
35. El Ghalbzouri, A., Gibbs, S., Lamme, E., Van Blitterswijk, C.A., and Ponec, M. Effect of fibroblasts on epidermal regeneration. Br J Dermatol 147, 230, 2002.
36. El Ghalbzouri A., and Ponec, M. Diffusible factors released by fibroblasts support epidermal morphogenesis and deposition of basement membrane components. Wound Repair Regen 12, 359, 2004.
37. Spiekstra, S.W., Breetveld, M., Rustemeyer, T., Scheper, R.J., and Gibbs, S. Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes. Wound Repair Regen 15, 708, 2007.
38. Kroeze, K.L., Boink, M.A., Sampat-Sardjoepersad, S.C., Waaijman, T., Scheper, R.J., and Gibbs, S. Autocrine regulation of re-epithelialization after wounding by chemokine receptors CCR1, CCR10, CXCR1, CXCR2, and CXCR3. J Invest Dermatol 132, 216, 2012.
39. van Drongelen, V., Alloul-Ramdhani, M., Danso, M.O., Mieremet, A., Mulder, A., van, S.J., et al. Knock-down of filaggrin does not affect lipid organization and composition in stratum corneum of reconstructed human skin equivalents. Exp Dermatol 22, 807, 2013.
40. Vaughan, M.B., Ramirez, R.D., Andrews, C.M., Wright, W.E., and Shay, J.W. H-ras expression in immortalized keratinocytes produces an invasive epithelium in cultured skin equivalents. PLoS One 4, e7908, 2009.
41. Blanton, R.A., Perez-Reyes, N., Merrick, D.T., and McDougall, J.K. Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture. Am J Pathol 138, 673, 1991.
42. Slavik, M.A., Allen-Hoffmann, B.L., Liu, B.Y., and Alexander, C.M. Wnt signaling induces differentiation of progenitor cells in organotypic keratinocyte cultures. BMC Dev Biol 7, 9, 2007.
43. Commandeur, S., van Drongelen V, de Gruijl, F.R., and El, G.A. Epidermal growth factor receptor activation and inhibition in 3D in vitro models of normal skin and human cutaneous squamous cell carcinoma. Cancer Sci 103, 2120, 2012.
44. Vaughan, M.B., Ramirez, R.D., Brown, S.A., Yang, J.C., Wright, W.E., and Shay, J.W. A reproducible laser-wounded skin equivalent model to study the effects of aging in vitro. Rejuvenation Res 7, 99, 2004.
45. Commandeur, S., de Gruijl, F.R., Willemze, R., Tensen, C.P., and El, G.A. An in vitro three-dimensional model of primary human cutaneous squamous cell carcinoma. Exp Dermatol 18, 849, 2009.
46. Schoop, V.M., Mirancea, N., and Fusenig, N.E. Epidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblasts. J Invest Dermatol 112, 343, 1999.
47. Okugawa, Y., and Hirai, Y. Overexpression of extracellular epimorphin leads to impaired epidermal differentiation in HaCaT keratinocytes. J Invest Dermatol 128, 1884, 2008.
48. Allen-Hoffmann, B.L., Schlosser, S.J., Ivarie, C.A., Sattler, C.A., Meisner, L.F., and O'Connor, S.L. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J Invest Dermatol 114, 444, 2000.
49. Gibson, A.L., Thomas-Virnig, C.L., Centanni, J.M., Schlosser, S.J., Johnston, C.E., Van Winkle, K.F., et al. Nonviral human beta defensin-3 expression in a bio-engineered human skin tissue: a therapeutic alternative for infected wounds. Wound Repair Regen 20, 414, 2012.
50. Dickson, M.A., Hahn, W.C., Ino, Y., Ronfard, V., Wu, J.Y., Weinberg, R.A., et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20, 1436, 2000.
51. Chapman, S., Liu, X., Meyers, C., Schlegel, R., and McBride, A.A. Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J Clin Invest 120, 2619, 2010.
52. van den Bogaard, E.H., Rodijk-Olthuis, D., Jansen, P.A., van Vlijmen-Willems, I.M., van Erp, P.E., Joosten, I., et al. Rho kinase inhibitor Y-27632 prolongs the life span of adult human keratinocytes, enhances skin equivalent development, and facilitates lentiviral transduction. Tissue Eng Part A 18, 1827, 2012.
53. van Drongelen, V., Danso, M.O., Mulder, A., Mieremet, A., van, S.J., Bouwstra, J.A., et al. Barrier properties of an N/ TERT based human skin equivalent. Tissue Eng Part A 20, 3041, 2014.
54. Shay, J.W., and Wright, W.E. Use of telomerase to create bioengineered tissues. Ann N Y Acad Sci 1057, 479, 2005.
55. Lee, K.M., Choi, K.H., and Ouellette, M.M. Use of exogenous hTERT to immortalize primary human cells. Cytotechnology 45, 33, 2004.
56. Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.P., Morin, G.B., Harley C.B., Shay, J.W., Lichtsteiner, S., and Wright, W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349, 1998.
57. Waaijman, T., Breetveld, M., Ulrich, M., Middelkoop, E., Scheper, R.J., and Gibbs, S. Use of a collagen-elastin matrix as transport carrier system to transfer proliferating epidermal cells to human dermis in vitro. Cell Transplant 19, 1339, 2010.
58. Kroeze, K.L., Jurgens, W.J., Doulabi, B.Z., van Milligen, F.J., Scheper, R.J., and Gibbs, S. Chemokine-mediated migration of skin-derived stem cells: predominant role for CCL5/RANTES. J Invest Dermatol 129, 1569, 2009.
59. Goldman, R. Growth factors and chronic wound healing: past, present, and future. Adv Skin Wound Care 17, 24, 2004.
60. Werner, S., and Grose, R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 83, 835, 2003.
61. Broughton, G., Janis, J.E., and Attinger, C.E. The basic science of wound healing. Plast Reconstr Surg 117, 12S, 2006.
62. Stark, H.J., Szabowski, A., Fusenig, N.E., and Maas- Szabowski, N. Organotypic cocultures as skin equivalents: a complex and sophisticated in vitro system. Biol Proced Online 6, 55, 2004.
63. Rasmussen, C., Gratz, K., Liebel, F., Southall, M., Garay, M., Bhattacharyya, S., et al. The StrataTest(R) human skin model, a consistent in vitro alternative for toxicological testing. Toxicol In Vitro 24, 2021, 2010.
64. Zanoni, T.B., Tiago, M., Faiao-Flores, F., de Moraes Barros, S.B., Bast, A., Hageman, G., et al. Basic Red 51, a permitted semi-permanent hair dye, is cytotoxic to human skin cells: studies in monolayer and 3D skin model using human keratinocytes (HaCaT). Toxicol Lett 227, 139, 2014.
65. Maas-Szabowski, N., Starker, A., and Fusenig, N.E. Epidermal tissue regeneration and stromal interaction in HaCaT cells is initiated by TGF-alpha. J Cell Sci 116, 2937, 2003.
66. Boelsma, E., Verhoeven, M.C., and Ponec, M. Reconstruction of a human skin equivalent using a spontaneously transformed keratinocyte cell line (HaCaT). J Invest Dermatol 112, 489, 1999.
67. Ponec, M., Gibbs, S., Pilgram, G., Boelsma, E., Koerten, H., Bouwstra, J., et al. Barrier function in reconstructed epidermis and its resemblance to native human skin. Skin Pharmacol Appl Skin Physiol 14 (Suppl 1), 63, 2001.
68. El Ghalbzouri A., Lamme, E., and Ponec, M. Crucial role of fibroblasts in regulating epidermal morphogenesis. Cell Tissue Res 310, 189, 2002.